Related Experiment Video
Updated: Apr 13, 2026
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Comparative costs of subcutaneous and sublingual immunotherapy
Christopher French1, Kristin Seiberling
1Department of Otolaryngology, Head and Neck Surgery, Loma Linda University, California, USA.
Purpose Of Review:
This article describes the most recent comparative cost evaluations for subcutaneous (SCIT) and sublingual (SLIT) immunotherapy.
Recent Findings:
Only one recent article compares the costs of SCIT and SLIT in America. No American publications assess direct and indirect costs together. Few studies outside of America assess these costs in detail.
Summary:
Limited data exist on the direct and indirect costs of SCIT and SLIT in the United States. Studies suggest that SLIT may be more affordable when taking indirect costs into account. Costs for SLIT may be more contained if physicians are more selective in the number and volume of antigens utilized per patient. Recent Food and Drug Administration approval of select sublingual tablets in America is changing the payment methodology for SLIT in America. Limited data on the cost in America call for further American studies on this topic.
Related Concept Videos
01:29Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:25Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
01:16Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...